Search

Your search keyword '"Heubner, Martin"' showing total 188 results

Search Constraints

Start Over You searched for: Author "Heubner, Martin" Remove constraint Author: "Heubner, Martin"
188 results on '"Heubner, Martin"'

Search Results

1. Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial

2. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

3. Patients With Endometrial Cancer: Exploring Comorbidities And Quality Of Life – First Results Of An International Survey (NOGGO, ENGOT, GCIG - IMPROVE/EXPRESSION XI)

4. Congenital Malformations of the Uterus

5. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

6. Supplementary Figure S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

7. Supplementary Table S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

8. Data from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

9. Supplementary Appendix S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

11. #435 Changes of lifestyle, exercise of precaution and preferences – interim results of an international survey for endometrial cancer patients (NOGGO, ENGOT, GCIG – expression XI/IMPROVE)

12. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group

14. Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

17. Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial

30. Optimal treatment duration of bevacizumab (BEV) combined with carboplatin and paclitaxel in patients (pts) with primary epithelial ovarian (EOC), fallopian tube (FTC) or peritoneal cancer (PPC): A multicenter open-label randomized 2-arm phase 3 ENGOT/GCIG trial of the AGO Study Group, GINECO, and NSGO (AGO-OVAR 17/BOOST, GINECO OV118, ENGOT Ov-15, NCT01462890).

32. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

33. P193 p53 and p16 expression profiles identify three prognostically subgroups in vulvar cancer : a TMA based study by the AGO-CaRE-translational study group : Poster exhibition Day 2

36. Suspensory Ligaments of the Female Genital Organs: MRI Evaluation with Intraoperative Correlation

38. BRCA-like classification in ovarian cancer : Results from the AGO-TRi-trial

39. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

40. BRCA-like classification in ovarian cancer: Results from the AGO-TR1-trial.

41. BRCA-like classification in ovarian cancer: Results from the AGO-TRi-trial.

42. Robot-assisted hysterectomy: a critical evaluation

43. Incidence of gernnline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1).

44. Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): A randomised, double-blind, placebo-controlled phase 3 trial

46. Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1).

49. Definition of compartment-based radical surgery in uterine cancer : Modified radical hysterectomy in intermediate/high-risk endometrial cancer using peritoneal mesometrial resection (PMMR) by M Höckel translated to robotic surgery

Catalog

Books, media, physical & digital resources